08/02/2012 6:10 pm Welcome to isteroids.com - BLOG

Monday 05, Jul 2010

  Preemies benefit when expectant mothers are administered with steroids

Posted By

Preemies benefit when expectant mothers are administered with steroidsAccording to a recent study conducted by researchers at the University of Adelaide, expectant mothers who run a risk of delivering babies much before the full term can benefit when administered with steroids.

Expecting mothers administered with daily doses of steroids experience reduced potential breathing difficulties during delivery.

From Bio-medicine.org:

Researchers studied 980 women and their 1100 babies from the Adelaide Women’s and Children’s Hospital. Research leader Professor Caroline Crowther said that while the benefit of a single steroid dose is established, the study sought to gauge the effectiveness of several doses of steroids.

She said ‘The results show that for babies who are exposed to the repeat steroids they had less lung disease when they were born. So they had less respiratory distress syndrome which is one of those complications of being born early.’

This finding is expected to have implications for helping medical practitioners in treating expectant mothers.

Tuesday 26, May 2009

  Additional doses of steroids can help Preemies

Posted By

Additional doses of steroids can help PreemiesA new research has proven that administering a second dose of steroids to babies while they are in the womb can minimize post-birth respiratory problems.

It was revealed that babies who were given a second dose of steroids require less of medical ventilation and many of them did not showed respiratory distress syndrome. The study was published in the March edition of the American Journal of Obstetrics and Gynecology.

From Bio-Medicine.Org:

Giving a second dose of steroids to babies still in the womb can reduce their post-birth respiratory problems and does not seem to affect their growth the way multiple courses can, new research shows.

In babies born before 34 weeks, about 43 percent of those given a second dose of steroids in utero had complications, compared with about 63 percent of the babies given a placebo.

“We saw a 31 percent reduction in overall composite neonatal morbidity. That’s highly significant,” said study author Dr. James Kurtzman, an associate clinical professor in the division of maternal-fetal medicine in the department of obstetrics and gynecology at the University of California, Irvine.

The real advantage, he added, came from the reduction in respiratory problems. Fewer babies had respiratory distress syndrome, and fewer babies needed mechanical ventilation.

It was also observed in the study that there was no evidence of growth restrictions or smaller head circumferences.

Dr. Peter Bernstein, a maternal-fetal medicine specialist at Montefiore Medical Center in New York City, said that the findings of this study will be helpful in reducing the counts of premature births and neonatal mortality in the United States.